tetano
Editor, Senior Moderator
Eur J Public Health
. 2023 Aug 25;ckad155.
doi: 10.1093/eurpub/ckad155. Online ahead of print. Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study
Alexander Domnich[SUP] 1 [/SUP], Andrea Orsi[SUP] 1 2 3 [/SUP], Matilde Ogliastro[SUP] 2 [/SUP], Carlo-Simone Trombetta[SUP] 2 [/SUP], Marianna Scarpaleggia[SUP] 2 [/SUP], Chiara Ceccaroli[SUP] 4 [/SUP], Carla Amadio[SUP] 4 [/SUP], Anna Raffo[SUP] 4 [/SUP], Luca Berisso[SUP] 4 [/SUP], Alla Yakubovich[SUP] 4 [/SUP], Giacomo Zappa[SUP] 4 [/SUP], Daniela Amicizia[SUP] 2 3 5 [/SUP], Donatella Panatto[SUP] 2 3 [/SUP], Giancarlo Icardi[SUP] 1 2 3 [/SUP]
Affiliations
Background: Missed opportunities constitute a main driver of suboptimal seasonal influenza vaccination (SIV) coverage in older adults. Vaccine co-administration is a way to reduce these missed opportunities. In this study, we quantified missed opportunities for SIV, identified some of their socio-structural correlates and documented SIV co-administration patterns.
Methods: In this registry-based retrospective cohort study, we verified the SIV status of all subjects aged ≥65 years who received at least one dose of coronavirus disease 2019 (COVID-19), pneumococcal or herpes zoster vaccines during the 2022/23 influenza season. The frequency of concomitant same-day administration of SIV with other target vaccines was also assessed.
Results: Among 41 112, 5482 and 3432 older adults who received ≥1 dose of COVID-19, pneumococcal and herpes zoster vaccines, missed opportunities for SIV accounted for 23.3%, 5.0% and 13.2%, respectively. Younger, male and foreign-born individuals were generally more prone to missing SIV. The co-administration of SIV with other recommended vaccines was relatively low, being 11.0%, 53.1% and 17.1% in COVID-19, pneumococcal and herpes zoster cohorts, respectively.
Conclusions: A sizeable proportion of older adults who received other recommended vaccines during the last influenza season did not receive SIV. This share of missed opportunities, which are subject to some social inequalities, may be addressed by increasing vaccine co-administration rates and implementing tailored health promotion interventions.
. 2023 Aug 25;ckad155.
doi: 10.1093/eurpub/ckad155. Online ahead of print. Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study
Alexander Domnich[SUP] 1 [/SUP], Andrea Orsi[SUP] 1 2 3 [/SUP], Matilde Ogliastro[SUP] 2 [/SUP], Carlo-Simone Trombetta[SUP] 2 [/SUP], Marianna Scarpaleggia[SUP] 2 [/SUP], Chiara Ceccaroli[SUP] 4 [/SUP], Carla Amadio[SUP] 4 [/SUP], Anna Raffo[SUP] 4 [/SUP], Luca Berisso[SUP] 4 [/SUP], Alla Yakubovich[SUP] 4 [/SUP], Giacomo Zappa[SUP] 4 [/SUP], Daniela Amicizia[SUP] 2 3 5 [/SUP], Donatella Panatto[SUP] 2 3 [/SUP], Giancarlo Icardi[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 37632235
- DOI: 10.1093/eurpub/ckad155
Background: Missed opportunities constitute a main driver of suboptimal seasonal influenza vaccination (SIV) coverage in older adults. Vaccine co-administration is a way to reduce these missed opportunities. In this study, we quantified missed opportunities for SIV, identified some of their socio-structural correlates and documented SIV co-administration patterns.
Methods: In this registry-based retrospective cohort study, we verified the SIV status of all subjects aged ≥65 years who received at least one dose of coronavirus disease 2019 (COVID-19), pneumococcal or herpes zoster vaccines during the 2022/23 influenza season. The frequency of concomitant same-day administration of SIV with other target vaccines was also assessed.
Results: Among 41 112, 5482 and 3432 older adults who received ≥1 dose of COVID-19, pneumococcal and herpes zoster vaccines, missed opportunities for SIV accounted for 23.3%, 5.0% and 13.2%, respectively. Younger, male and foreign-born individuals were generally more prone to missing SIV. The co-administration of SIV with other recommended vaccines was relatively low, being 11.0%, 53.1% and 17.1% in COVID-19, pneumococcal and herpes zoster cohorts, respectively.
Conclusions: A sizeable proportion of older adults who received other recommended vaccines during the last influenza season did not receive SIV. This share of missed opportunities, which are subject to some social inequalities, may be addressed by increasing vaccine co-administration rates and implementing tailored health promotion interventions.